BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23347778)

  • 1. Oncological outcome of patients with deeply located soft tissue sarcoma of the pelvis: a follow up study at minimum 5 years after diagnosis.
    Nakamura T; Abudu A; Murata H; Grimer RJ; Carter SR; Tillman RM; Jeys L
    Eur J Surg Oncol; 2013 Sep; 39(9):1030-5. PubMed ID: 23347778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
    Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do patients with low-grade soft tissue sarcoma die?
    Canter RJ; Qin LX; Ferrone CR; Maki RG; Singer S; Brennan MF
    Ann Surg Oncol; 2008 Dec; 15(12):3550-60. PubMed ID: 18830667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients.
    Alldinger I; Yang Q; Pilarsky C; Saeger HD; Knoefel WT; Peiper M
    Anticancer Res; 2006; 26(2B):1577-81. PubMed ID: 16619574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological assessment of T1 soft tissue sarcomas.
    Tsukushi S; Nishida Y; Wasa J; Urakawa H; Ishiguro N
    Arch Orthop Trauma Surg; 2011 May; 131(5):695-9. PubMed ID: 21212970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-muscular location in soft tissue sarcomas: impact on oncologic outcome.
    Kim HS; Kim JH; Lee SA; Han I
    Eur J Surg Oncol; 2014 Sep; 40(9):1131-5. PubMed ID: 24565916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical and oncological outcomes after hindquarter amputation for pelvic sarcoma.
    Kiiski J; Parry MC; Le Nail LR; Sumathi V; Stevenson JD; Kaartinen IS; Jeys LM; Laitinen MK
    Bone Joint J; 2020 Jun; 102-B(6):788-794. PubMed ID: 32475235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in Extremity Soft-Tissue Sarcoma Outcomes: A Nationwide Analysis.
    Alamanda VK; Song Y; Schwartz HS; Holt GE
    Am J Clin Oncol; 2015 Dec; 38(6):595-9. PubMed ID: 24401671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?
    Sawamura C; Matsumoto S; Shimoji T; Tanizawa T; Ae K
    Clin Orthop Relat Res; 2012 Mar; 470(3):700-5. PubMed ID: 21826540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?
    Gladdy RA; Qin LX; Moraco N; Edgar MA; Antonescu CR; Alektiar KM; Brennan MF; Singer S
    J Clin Oncol; 2010 Apr; 28(12):2064-9. PubMed ID: 20308666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
    Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
    Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
    Dhakal S; Corbin KS; Milano MT; Philip A; Sahasrabudhe D; Jones C; Constine LS
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):940-5. PubMed ID: 21277105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
    Mullen JT; Hornicek FJ; Harmon DC; Raskin KA; Chen YL; Szymonifka J; Yeap BY; Choy E; DeLaney TF; Nielsen GP
    Cancer; 2014 Dec; 120(23):3676-82. PubMed ID: 25081640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High grade soft tissue sarcoma of the flexor fossae. Size rather than compartmental status determine prognosis.
    Yang RS; Lane JM; Eilber FR; Dorey FJ; al-Shaikh R; Schumacher LY; Rosen G; Forscher CA; Eckardt JJ
    Cancer; 1995 Oct; 76(8):1398-405. PubMed ID: 8620414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of treating by histological subtype in advanced soft tissue sarcoma.
    Martín Broto J; Le Cesne A; Reichardt P
    Future Oncol; 2017 Jan; 13(1s):23-31. PubMed ID: 27918201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.